Dual inhibitors of CDK2 and TRKA kinases: design, synthesis, antiproliferative activity and molecular modeling of novel pyrazolopyrimidine derivatives.

Attia MH, Lasheen DS, Samir N, Taher AT, Abdel-Aziz HA, Abou El Ella DA.

Open source

DOI
10.1039/d6ra02521h
Published
2026-09-16
Container
RSC Adv
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6ra02521h,
  title = {Dual inhibitors of CDK2 and TRKA kinases: design, synthesis, antiproliferative activity and molecular modeling of novel pyrazolopyrimidine derivatives.},
  author = {Attia MH and  Lasheen DS and  Samir N and  Taher AT and  Abdel-Aziz HA and  Abou El Ella DA.},
  year = {2026},
  journal = {RSC Adv},
  doi = {10.1039/d6ra02521h},
  url = {https://doi.org/10.1039/d6ra02521h}
}

RIS

TY  - JOUR
TI  - Dual inhibitors of CDK2 and TRKA kinases: design, synthesis, antiproliferative activity and molecular modeling of novel pyrazolopyrimidine derivatives.
AU  - Attia MH
AU  -  Lasheen DS
AU  -  Samir N
AU  -  Taher AT
AU  -  Abdel-Aziz HA
AU  -  Abou El Ella DA.
PY  - 2026
JO  - RSC Adv
DO  - 10.1039/d6ra02521h
UR  - https://doi.org/10.1039/d6ra02521h
ER  - 

APA

MH, A., DS, L., N, S., AT, T., HA, A., & DA., A. E. E. (2026). Dual inhibitors of CDK2 and TRKA kinases: design, synthesis, antiproliferative activity and molecular modeling of novel pyrazolopyrimidine derivatives.. RSC Adv. https://doi.org/10.1039/d6ra02521h

Source records